Is Jazz Pharmaceuticals PLC halal to invest in?

As of July 2026, Jazz Pharmaceuticals PLC JAZZ is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.

Is Jazz Pharmaceuticals PLC a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Jazz Pharmaceuticals PLC using these criteria to determine its compliance status.

Can Muslims buy shares of Jazz Pharmaceuticals PLC?

Muslim investors may consider investing in Jazz Pharmaceuticals PLC if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Jazz Pharmaceuticals PLC classified as NOT HALAL?

Musaffa determines the Shariah status of Jazz Pharmaceuticals PLC by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Jazz Pharmaceuticals PLC updated?

The Shariah compliance status of Jazz Pharmaceuticals PLC may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Jazz Pharmaceuticals PLC become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Jazz Pharmaceuticals PLC?

You can check the latest Shariah compliance status of Jazz Pharmaceuticals PLC on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

JAZZ Shariah Compliance

Screening Methodology: AAOIFI

As of July 2026, Jazz Pharmaceuticals PLC is classified as not halal.

NOT HALAL

Report Source: 2026 1st Quarter Report

Jazz Pharmaceuticals PLC. Stock Analysis JAZZ

United States Health Care Large Cap Report: Q1, 2026

Jazz Pharmaceuticals Plc operates as a biopharmaceutical company, which focuses on the identification, development, and commercialization of pharmaceutical products in the areas of narcolepsy, oncology, pain, and psychiatry. The company is engaged in developing medicines for people with serious diseases, often with limited or no therapeutic options. The company has a diverse portfolio of marketed medicines, including therapies for sleep disorders and epilepsy, and a portfolio of cancer treatments. Its lead-marketed products include Xywav (calcium, magnesium, potassium, and sodium oxybates) oral solution, Epidiolex (cannabidiol) oral solution, Rylaze (asparaginase erwinia chrysanthemi (recombinant)-rywn), Zepzelca (lurbinectedin), Ziihera (zanidatamab-hrii), and Enrylaze (recombinant crisantaspase). Its product candidates include Zanidatamab, Vyxeos, JZP815, JZP898, JZP441, and others. Xywav is used for the treatment of cataplexy or EDS in patients seven years of age and older with narcolepsy. The Company, through Chimerix, Inc., also owns a clinical asset, dordaviprone, a novel small molecule treatment in development for H3 K27M-mutant diffuse glioma.

Key Statistics of Jazz Pharmaceuticals PLC (JAZZ)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$252.09$257.00

Today's Open

$254.79

Volume

771.88K

P/E Ratio (TTM)

52 Week Range

$105.00$256.75

Market Cap

15.59B

Avg. Volume

737.73K

Dividend Yield

Financial Metrics & Statements of Jazz Pharmaceuticals PLC (JAZZ)

Super Investors Invested in Jazz Pharmaceuticals PLC (JAZZ)

FAQ's for Jazz Pharmaceuticals PLC (JAZZ)

As of July 2026, Jazz Pharmaceuticals PLC JAZZ is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Jazz Pharmaceuticals PLC using these criteria to determine its compliance status.
Muslim investors may consider investing in Jazz Pharmaceuticals PLC if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
Musaffa determines the Shariah status of Jazz Pharmaceuticals PLC by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
The Shariah compliance status of Jazz Pharmaceuticals PLC may be updated periodically when new financial statements, earnings reports, or business activity information become available.
Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
You can check the latest Shariah compliance status of Jazz Pharmaceuticals PLC on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.